APA (7th ed.) Citation

Lan, Z., Qu, L., Liang, Y., Chen, L., Xu, S., Ge, J., . . . Zhu, X. (2024). AZD1390, an ataxia telangiectasia mutated inhibitor, attenuates microglia‐mediated neuroinflammation and ischemic brain injury. CNS Neuroscience & Therapeutics, 30(4), 1. https://doi.org/10.1111/cns.14696

Chicago Style (17th ed.) Citation

Lan, Zhen, et al. "AZD1390, an Ataxia Telangiectasia Mutated Inhibitor, Attenuates Microglia‐mediated Neuroinflammation and Ischemic Brain Injury." CNS Neuroscience & Therapeutics 30, no. 4 (2024): 1. https://doi.org/10.1111/cns.14696.

MLA (9th ed.) Citation

Lan, Zhen, et al. "AZD1390, an Ataxia Telangiectasia Mutated Inhibitor, Attenuates Microglia‐mediated Neuroinflammation and Ischemic Brain Injury." CNS Neuroscience & Therapeutics, vol. 30, no. 4, 2024, p. 1, https://doi.org/10.1111/cns.14696.